The D-7D and the P-7D group also showed an increasing trend in these indicators compared to the CON group, but without statistical significance.
← all excerpts
The GLP-1 receptor agonist liraglutide inhibits necroptosis and neuroinflammation in a mouse model of Parkinson's disease with diabetes co-morbidity.
1
—
—